WO2014086373A1 - Cristallisation d'oligosaccharides de lait humain - Google Patents
Cristallisation d'oligosaccharides de lait humain Download PDFInfo
- Publication number
- WO2014086373A1 WO2014086373A1 PCT/DK2013/050416 DK2013050416W WO2014086373A1 WO 2014086373 A1 WO2014086373 A1 WO 2014086373A1 DK 2013050416 W DK2013050416 W DK 2013050416W WO 2014086373 A1 WO2014086373 A1 WO 2014086373A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hmo
- acidic
- alcohol solution
- alcohol
- drying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- HMOs could be isolated in crystalline form from the aqueous enzymatic or fermentation media, in which the HMOs were produced, that would provide a simple and cheap method to separate the HMOs from contaminants in such aqueous media and obtain the HMOs as pure products. Indeed, purification and isolation by crystallization generally makes any process more attractive and cost-effective industrially. See EP-A-1405856. However, there has, to date, been no commercially suitable method for purifying and isolating, by crystallization, HMOs produced enzymatically or by fermentation.
- non-acidic preferably refers to a compound containing no carboxyl group, e.g., no sialic acid group.
- non-acidic human milk oligosaccharide or “non- acidic HMO” preferably means a compound with one of the following core structures or desialylated analogs thereof:
- Particularly preferred non-acidic HMOs include:
- non-acidic precursor of a human milk oligosaccharide or “non-acidic HMO precursor” preferably means fucose, N-acetyl glucosamine, galactose, N-acetyl lactosamine, lacto-N-biose or lacto-N-triose II.
- the dry, preferably protein-free powder is then treated with a hot, preferably boiling, d-C 6 alcohol solvent, preferably a CrC 4 alcohol solvent, especially methanol, to produce an alcohol solution of the non-acidic HMO or HMO precursor.
- a hot, preferably boiling, d-C 6 alcohol solvent preferably a CrC 4 alcohol solvent, especially methanol
- the alcohol solvent can, if desired, be heated, preferably to boiling, only after it is used to dissolve the non-acidic HMO or HMO precursor to produce the alcohol solution.
- non-acidic HMOs and precursors are crystallized in essentially the same manner after fermentation thereof: lacto-N-triose II (US 7521212, Priem et al. Glycobiology 12, 235 [2002]), LNnT( US 7521212, or Priem et al. Glycobiology ⁇ 2, 235 [2002]),
Abstract
La présente invention porte sur un procédé d'obtention d'un oligosaccharide du lait humain (HMO) non acide ou d'un précurseur de celui-ci sous forme cristalline à partir d'un milieu aqueux, tel qu'un bouillon de fermentation, par séchage du milieu aqueux suivi d'un traitement de celui-ci avec un solvant alcoolique C1-C6 chaud.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201270770 | 2012-12-07 | ||
DKPA201270770 | 2012-12-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014086373A1 true WO2014086373A1 (fr) | 2014-06-12 |
Family
ID=49841470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2013/050416 WO2014086373A1 (fr) | 2012-12-07 | 2013-12-05 | Cristallisation d'oligosaccharides de lait humain |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2014086373A1 (fr) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015188834A1 (fr) * | 2014-06-11 | 2015-12-17 | Glycom A/S | Séparation du 2'-o-fucosyllactose contenu dans un bouillon de fermentation |
WO2016086947A1 (fr) * | 2014-12-05 | 2016-06-09 | Glycom A/S | Difucosyllactose cristallin |
WO2016095924A1 (fr) | 2014-12-16 | 2016-06-23 | Glycom A/S | Séparation de 2'-fl d'un bouillon de fermentation |
WO2017101953A1 (fr) * | 2015-12-17 | 2017-06-22 | Glycom A/S | Formes cristallines de lnt |
WO2017182965A1 (fr) * | 2016-04-19 | 2017-10-26 | Glycom A/S | Séparation d'oligosaccharides d'un bouillon de fermentation |
WO2017221208A1 (fr) | 2016-06-24 | 2017-12-28 | Glycom A/S | Composés comprenant des hmos pour la prévention et/ou le traitement d'infections virales et/ou bactériennes. |
WO2018077368A1 (fr) | 2016-10-31 | 2018-05-03 | Glycom A/S | Procédé d'élimination de solvant organique résiduel d'un oligosaccharide cristallin |
EP3494805A1 (fr) * | 2017-12-08 | 2019-06-12 | Jennewein Biotechnologie GmbH | Tétrasaccharide séché en pulvérisation |
EP3494804A1 (fr) * | 2017-12-08 | 2019-06-12 | Jennewein Biotechnologie GmbH | 3-fucosyllactose séché en pulvérisation |
EP3494807A1 (fr) * | 2017-12-11 | 2019-06-12 | Jennewein Biotechnologie GmbH | Sialyllactose séché par pulvérisation |
EP3494806A1 (fr) * | 2017-12-08 | 2019-06-12 | Jennewein Biotechnologie GmbH | Lacto-n-fucopentaose séché par pulvérisation |
WO2019110803A1 (fr) * | 2017-12-08 | 2019-06-13 | Jennewein Biotechnologie Gmbh | Sialyllactose séché par atomisation |
US10407516B2 (en) * | 2016-10-31 | 2019-09-10 | Glycom A/S | Crystalline HMO |
EP3546060A1 (fr) * | 2018-03-27 | 2019-10-02 | DuPont Nutrition Biosciences ApS | Procédé de séchage par pulvérisation de solutions de fucosyllactose et de compositions de produit correspondantes |
WO2019189200A1 (fr) | 2018-03-29 | 2019-10-03 | 森永乳業株式会社 | Composition nutritionnelle, composition alimentaire/de boisson utilisant la composition nutritionnelle et poudre de lait modifiée utilisant la composition nutritionnelle |
EP3131912B1 (fr) | 2014-01-20 | 2020-01-22 | Jennewein Biotechnologie GmbH | Procede de purification efficace d' oligosaccharides neutres du lait humain (hmo) a partir de la fermentation microbienne |
WO2020079146A1 (fr) | 2018-10-18 | 2020-04-23 | Basf Se | Forme cristalline ii du 2'-o-fucosyllactose, son procédé de préparation, formulation nutritionnelle, cosmétique ou pharmaceutique le contenant |
EP3750902A1 (fr) * | 2019-06-14 | 2020-12-16 | Jennewein Biotechnologie GmbH | Procede de purification de lacto-n-neotetraose |
US11505567B2 (en) | 2017-07-12 | 2022-11-22 | Glycom A/S | Amorphous mixture comprising a neutral mono- or oligosaccharide and an acidic non-carbohydrate component |
CN115873051A (zh) * | 2022-05-17 | 2023-03-31 | 山东恒鲁生物科技有限公司 | 三糖的新晶型 |
RU2793915C1 (ru) * | 2019-06-14 | 2023-04-10 | Хр. Ханзен ХМО ГмбХ | Способ очистки лакто-n-неотетраозы |
CN116425810A (zh) * | 2023-06-14 | 2023-07-14 | 山东合成远景生物科技有限公司 | 一种混合液中3-岩藻糖基乳糖的纯化方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001004341A1 (fr) | 1999-07-07 | 2001-01-18 | Centre National De La Recherche Scientifique (Cnrs) | Procede de production d'oligosaccharides |
EP1405856A1 (fr) | 2001-06-11 | 2004-04-07 | Kyowa Hakko Kogyo Co., Ltd | Cristaux d'oligosaccharides et procedes de preparation correspondants |
WO2010070104A1 (fr) | 2008-12-19 | 2010-06-24 | Jennewein Biotechnologie Gmbh | Synthèse de composés fucosylés |
WO2010142305A1 (fr) | 2009-06-08 | 2010-12-16 | Jennewein Biotechnologie Gmbh | Synthèse de hmo |
WO2011100980A1 (fr) * | 2010-02-19 | 2011-08-25 | Glycom A/S | Procédé pour la préparation du tétrasaccharide lacto-n-néotétraose (lnnt) contenant de la n-acétyllactosamine |
WO2011150939A1 (fr) * | 2010-06-01 | 2011-12-08 | Glycom A/S | Formes polymorphiques du 2'-o-fucosyllactose et leurs procédés de production |
WO2012112777A2 (fr) | 2011-02-16 | 2012-08-23 | Glycosyn LLC | Biosynthèse d'oligosaccharides de lait humain dans des bactéries manipulées |
-
2013
- 2013-12-05 WO PCT/DK2013/050416 patent/WO2014086373A1/fr active Application Filing
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001004341A1 (fr) | 1999-07-07 | 2001-01-18 | Centre National De La Recherche Scientifique (Cnrs) | Procede de production d'oligosaccharides |
EP1194584A1 (fr) | 1999-07-07 | 2002-04-10 | Centre National De La Recherche Scientifique (Cnrs) | Procede de production d'oligosaccharides |
US7521212B1 (en) | 1999-07-07 | 2009-04-21 | Centre National De La Recherche Scientifique (Cnrs) | Method for producing oligopolysaccharides |
EP1405856A1 (fr) | 2001-06-11 | 2004-04-07 | Kyowa Hakko Kogyo Co., Ltd | Cristaux d'oligosaccharides et procedes de preparation correspondants |
WO2010070104A1 (fr) | 2008-12-19 | 2010-06-24 | Jennewein Biotechnologie Gmbh | Synthèse de composés fucosylés |
WO2010142305A1 (fr) | 2009-06-08 | 2010-12-16 | Jennewein Biotechnologie Gmbh | Synthèse de hmo |
WO2011100980A1 (fr) * | 2010-02-19 | 2011-08-25 | Glycom A/S | Procédé pour la préparation du tétrasaccharide lacto-n-néotétraose (lnnt) contenant de la n-acétyllactosamine |
WO2011150939A1 (fr) * | 2010-06-01 | 2011-12-08 | Glycom A/S | Formes polymorphiques du 2'-o-fucosyllactose et leurs procédés de production |
WO2012112777A2 (fr) | 2011-02-16 | 2012-08-23 | Glycosyn LLC | Biosynthèse d'oligosaccharides de lait humain dans des bactéries manipulées |
Non-Patent Citations (10)
Title |
---|
DROUILLARD ET AL., AGNEW. CHEM. INT. ED., vol. 45, 2006, pages 1778 |
DROUILLARD ET AL., ANGEW. CHEM. INT. ED., vol. 45, 2006, pages 1778 |
DUMON ET AL., BIOTECHNOL. PROG., vol. 20, 2004, pages 412 |
DUMON ET AL., GLYCOCONJ. J., vol. 18, 2001, pages 465 |
HAN ET AL., BIOTECHNOL. ADV., vol. 30, 2012, pages 1268 |
NAM SOO HAN ET AL: "Biotechnological production of human milk oligosaccharides", BIOTECHNOLOGY ADVANCES, vol. 30, no. 6, 1 November 2012 (2012-11-01), pages 1268 - 1278, XP055074947, ISSN: 0734-9750, DOI: 10.1016/j.biotechadv.2011.11.003 * |
PRIEM ET AL., GLYCOBIOLOGY, vol. 12, 2002, pages 235 |
RICHARD KUHN ET AL: "Die Konstitution der Lacto-N-fucopentaose II. Ein Beitrag zur Spezifität der Blutgruppensubstanz Lea", CHEMISCHE BERICHTE, 1 February 1958 (1958-02-01), pages 364 - 374, XP055113657, Retrieved from the Internet <URL:http://onlinelibrary.wiley.com/store/10.1002/cber.19580910221/asset/19580910221_ftp.pdf?v=1&t=htv66hdf&s=a346c0e574efb3f1dc49129665d53ba15d3be5db> DOI: 10.1002/cber.19580910221 * |
RICHARD KUHN ET AL: "KRISTALLISIERTE FUCOSIDO-LACTOSE", CHEMISCHE BERICHTE, VCH, DE, vol. 89, no. 11, 1 November 1956 (1956-11-01), pages 2513, XP009074773, ISSN: 0009-2940 * |
URASHIMA ET AL.: "Milk Oligosaccharides", 2011, NOVA BIOMEDICAL BOOKS |
Cited By (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11661435B2 (en) | 2014-01-20 | 2023-05-30 | Chr. Hansen HMO GmbH | Spray-dried, high-purity, neutral human milk oligosaccharides (HMOs) from microbial fermentation |
EP3131912B1 (fr) | 2014-01-20 | 2020-01-22 | Jennewein Biotechnologie GmbH | Procede de purification efficace d' oligosaccharides neutres du lait humain (hmo) a partir de la fermentation microbienne |
EP3686211B1 (fr) | 2014-01-20 | 2023-03-01 | Chr. Hansen HMO GmbH | Procédé permettant de purifier efficacement des oligosaccharides du lait humain neutre (hmos) à partir de la fermentation microbienne |
EP3680249B1 (fr) | 2014-01-20 | 2023-03-01 | Chr. Hansen HMO GmbH | Procédé de purification efficace d' oligosaccharides neutres du lait humain (hmos) à partir de la fermentation microbienne |
US11597740B2 (en) | 2014-01-20 | 2023-03-07 | Chr. Hansen HMO GmbH | Process for efficient purification of neutral human milk oligosaccharides (HMOs) from microbial fermentation |
WO2015188834A1 (fr) * | 2014-06-11 | 2015-12-17 | Glycom A/S | Séparation du 2'-o-fucosyllactose contenu dans un bouillon de fermentation |
WO2016086947A1 (fr) * | 2014-12-05 | 2016-06-09 | Glycom A/S | Difucosyllactose cristallin |
EP3227309A4 (fr) * | 2014-12-05 | 2019-01-16 | Glycom A/S | Difucosyllactose cristallin |
US10500221B2 (en) | 2014-12-05 | 2019-12-10 | Glycom A/S | Crystalline difucosyllactose |
US10676770B2 (en) | 2014-12-16 | 2020-06-09 | Glycom A/S | Separation of 2′-FL from a fermentation broth |
EP4151645A2 (fr) | 2014-12-16 | 2023-03-22 | Glycom A/S | Séparation de 2'-fl d'un bouillon de fermentation |
WO2016095924A1 (fr) | 2014-12-16 | 2016-06-23 | Glycom A/S | Séparation de 2'-fl d'un bouillon de fermentation |
US11767340B2 (en) | 2015-12-17 | 2023-09-26 | Glycom A/S | Crystalline forms of LNT |
US10696705B2 (en) | 2015-12-17 | 2020-06-30 | Glycom A/S | Crystalline forms of LNT |
WO2017101953A1 (fr) * | 2015-12-17 | 2017-06-22 | Glycom A/S | Formes cristallines de lnt |
US11267839B2 (en) | 2015-12-17 | 2022-03-08 | Glycom A/S | Crystalline forms of LNT |
WO2017182965A1 (fr) * | 2016-04-19 | 2017-10-26 | Glycom A/S | Séparation d'oligosaccharides d'un bouillon de fermentation |
US11312741B2 (en) | 2016-04-19 | 2022-04-26 | Glycom A/S | Separation of oligosaccharides from fermentation broth |
WO2017221208A1 (fr) | 2016-06-24 | 2017-12-28 | Glycom A/S | Composés comprenant des hmos pour la prévention et/ou le traitement d'infections virales et/ou bactériennes. |
WO2018077368A1 (fr) | 2016-10-31 | 2018-05-03 | Glycom A/S | Procédé d'élimination de solvant organique résiduel d'un oligosaccharide cristallin |
US11384110B2 (en) | 2016-10-31 | 2022-07-12 | Glycom A/S | Method for removing residual organic solvent from a crystalline oligosaccharide |
US10407516B2 (en) * | 2016-10-31 | 2019-09-10 | Glycom A/S | Crystalline HMO |
US11505567B2 (en) | 2017-07-12 | 2022-11-22 | Glycom A/S | Amorphous mixture comprising a neutral mono- or oligosaccharide and an acidic non-carbohydrate component |
US11939351B2 (en) | 2017-07-12 | 2024-03-26 | Glycom A/S | Amorphous mixture comprising a neutral mono- or oligosaccharide and an acidic non-carbohydrate component |
WO2019110804A1 (fr) * | 2017-12-08 | 2019-06-13 | Jennewein Biotechnologie Gmbh | Tétrasaccharides séchés par atomisation |
RU2812853C2 (ru) * | 2017-12-08 | 2024-02-02 | Хр. Ханзен ХМО ГмбХ | Высушенные распылением тетрасахариды |
CN111447844A (zh) * | 2017-12-08 | 2020-07-24 | 詹尼温生物技术有限责任公司 | 喷雾干燥的四糖 |
CN111465331A (zh) * | 2017-12-08 | 2020-07-28 | 詹尼温生物技术有限责任公司 | 喷雾干燥的3-岩藻糖基乳糖 |
EP3494806A1 (fr) * | 2017-12-08 | 2019-06-12 | Jennewein Biotechnologie GmbH | Lacto-n-fucopentaose séché par pulvérisation |
EP3494805A1 (fr) * | 2017-12-08 | 2019-06-12 | Jennewein Biotechnologie GmbH | Tétrasaccharide séché en pulvérisation |
RU2812864C2 (ru) * | 2017-12-08 | 2024-02-05 | Хр. Ханзен ХМО ГмбХ | Высушенная распылением лакто-n-фукопентаоза |
JP2021505177A (ja) * | 2017-12-08 | 2021-02-18 | イェンネワイン バイオテクノロジー ゲーエムベーハーJennewein Biotechnologie GmbH | 噴霧乾燥四糖 |
JP2021505174A (ja) * | 2017-12-08 | 2021-02-18 | イェンネワイン バイオテクノロジー ゲーエムベーハーJennewein Biotechnologie GmbH | 噴霧乾燥ラクト−n−フコペンタオース |
CN111432663A (zh) * | 2017-12-08 | 2020-07-17 | 詹尼温生物技术有限责任公司 | 喷雾干燥的乳-n-岩藻戊糖 |
WO2019110803A1 (fr) * | 2017-12-08 | 2019-06-13 | Jennewein Biotechnologie Gmbh | Sialyllactose séché par atomisation |
WO2019110806A1 (fr) * | 2017-12-08 | 2019-06-13 | Jennewein Biotechnologie Gmbh | Lacto-n-fucopentaose séché par pulvérisation |
RU2810298C2 (ru) * | 2017-12-08 | 2023-12-26 | Хр. Ханзен ХМО ГмбХ | Высушенная распылением 3-фукозиллактоза |
EP3494804A1 (fr) * | 2017-12-08 | 2019-06-12 | Jennewein Biotechnologie GmbH | 3-fucosyllactose séché en pulvérisation |
WO2019110801A1 (fr) * | 2017-12-08 | 2019-06-13 | Jennewein Biotechnologie Gmbh | 3-fucosyllactose séché par atomisation |
US11582994B2 (en) | 2017-12-08 | 2023-02-21 | Chr. Hansen HMO GmbH | Spray-dried 3-fucosyllactose |
EP3494807A1 (fr) * | 2017-12-11 | 2019-06-12 | Jennewein Biotechnologie GmbH | Sialyllactose séché par pulvérisation |
EP3755819A4 (fr) * | 2018-02-19 | 2021-12-29 | DuPont Nutrition Biosciences ApS | Procédé de séchage par pulvérisation de solutions de fucosyllactose et compositions de produit associées |
CN112020568A (zh) * | 2018-02-19 | 2020-12-01 | 杜邦营养生物科学有限公司 | 用于喷雾干燥岩藻糖基乳糖溶液的方法及相关产品组合物 |
EP3546060A1 (fr) * | 2018-03-27 | 2019-10-02 | DuPont Nutrition Biosciences ApS | Procédé de séchage par pulvérisation de solutions de fucosyllactose et de compositions de produit correspondantes |
WO2019189200A1 (fr) | 2018-03-29 | 2019-10-03 | 森永乳業株式会社 | Composition nutritionnelle, composition alimentaire/de boisson utilisant la composition nutritionnelle et poudre de lait modifiée utilisant la composition nutritionnelle |
CN113227112A (zh) * | 2018-10-18 | 2021-08-06 | 巴斯夫欧洲公司 | 获得晶体2′-岩藻糖基乳糖的方法 |
US11685759B2 (en) | 2018-10-18 | 2023-06-27 | Basf Se | Method for obtaining crystalline 2′-fucosyllactose |
WO2020079146A1 (fr) | 2018-10-18 | 2020-04-23 | Basf Se | Forme cristalline ii du 2'-o-fucosyllactose, son procédé de préparation, formulation nutritionnelle, cosmétique ou pharmaceutique le contenant |
WO2020079114A1 (fr) | 2018-10-18 | 2020-04-23 | Basf Se | Procédé d'obtention de 2'-fucosyllactose cristallin |
RU2793915C1 (ru) * | 2019-06-14 | 2023-04-10 | Хр. Ханзен ХМО ГмбХ | Способ очистки лакто-n-неотетраозы |
CN113966338A (zh) * | 2019-06-14 | 2022-01-21 | 科汉森母乳低聚糖股份有限公司 | 纯化乳-n-新四糖的方法 |
WO2020249584A1 (fr) * | 2019-06-14 | 2020-12-17 | Jennewein Biotechnologie Gmbh | Procédé pour la purification du lacto-n-néotétraose |
EP3750902A1 (fr) * | 2019-06-14 | 2020-12-16 | Jennewein Biotechnologie GmbH | Procede de purification de lacto-n-neotetraose |
CN115873051A (zh) * | 2022-05-17 | 2023-03-31 | 山东恒鲁生物科技有限公司 | 三糖的新晶型 |
WO2023221758A1 (fr) * | 2022-05-17 | 2023-11-23 | 山东恒鲁生物科技有限公司 | Nouvelle forme cristalline de trisaccharide |
CN116425810A (zh) * | 2023-06-14 | 2023-07-14 | 山东合成远景生物科技有限公司 | 一种混合液中3-岩藻糖基乳糖的纯化方法 |
CN116425810B (zh) * | 2023-06-14 | 2023-08-11 | 山东合成远景生物科技有限公司 | 一种混合液中3-岩藻糖基乳糖的纯化方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014086373A1 (fr) | Cristallisation d'oligosaccharides de lait humain | |
EP3714060B1 (fr) | Procédé de purification d'un acide sialique à partir d'un bouillon de fermentation | |
DK202000086U1 (en) | Separation of 2'-fl from a fermentation broth | |
RU2041234C1 (ru) | КРИСТАЛЛИЧЕСКАЯ 2-О- α -D-ГЛЮКОПИРАНОЗИЛ-L-АСКОРБИНОВАЯ КИСЛОТА И СПОСОБ ЕЕ ПОЛУЧЕНИЯ | |
EP3233875B1 (fr) | Séparation de 2'-fl d'un bouillon de fermentation | |
FI103119B (fi) | Menetelmä ramnoosin valmistamiseksi ramnolipideistä | |
WO2016086947A1 (fr) | Difucosyllactose cristallin | |
CN110914284A (zh) | 包含中性单糖或寡糖和酸性非碳水化合物组分的无定形混合物 | |
EP3746456A1 (fr) | Forme cristalline ii du 2'-o-fucosyllactose, son procédé de préparation, formulation nutritionnelle, cosmétique ou pharmaceutique le contenant | |
CN111171097B (zh) | 发酵生产腺苷的分离纯化方法 | |
US20220251131A1 (en) | Process for the purification of lacto-n-neotetraose | |
WO2021181349A1 (fr) | Cristallisation du 2'-fl | |
US8580955B2 (en) | Purification method and production method for cellobiose | |
RU2793915C1 (ru) | Способ очистки лакто-n-неотетраозы | |
JPH08119986A (ja) | シアル酸またはその類縁体の精製方法 | |
RU2780437C1 (ru) | Способ очистки сиаловой кислоты из ферментационного бульона | |
KR20190126350A (ko) | 2'-푸코실락토스 결정화 방법 및 관련 조성물 | |
CN108265094B (zh) | 一种α-2,3脱氨基唾液酸乳果糖制备方法 | |
KR940004080B1 (ko) | L-람노오스의 제조방법. | |
JPH0699461B2 (ja) | L−ラムノ−スの製造方法 | |
NZ717489B2 (en) | Production of galacto-oligosaccharides. | |
JPH08228792A (ja) | キシロースのアミノ酸配糖体の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13811117 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13811117 Country of ref document: EP Kind code of ref document: A1 |